Patient Guide: A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 220 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06684847
Status: 🟢 Enrolling Now
Condition: Primary Sjogrens Disease
Phase: PHASE3

Where You Can Participate

This study is available at 220 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Sun City, Arizona
  • • Tucson, Arizona
  • • And 217 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome - Join Clinical Trial NCTNCT06684847

How to Join This Clinical Trial - NCTNCT06684847

Learn how to participate in this PHASE3 trial studying an investigational therapy for Primary Sjogrens Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Primary Sjogrens Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Primary Sjogrens Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06684847 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 220 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85258 - United States

Status: RECRUITING

Clinical Research Site

Sun City, Arizona 85351 - United States

Status: RECRUITING

Clinical Research Site

Tucson, Arizona 85748 - United States

Status: RECRUITING

Clinical Research Site

Fullerton, California 92835 - United States

Status: RECRUITING

Clinical Research Site

Clearwater, Florida 33765 - United States

Status: RECRUITING

Clinical Research Site

Fort Lauderdale, Florida 33309 - United States

Status: RECRUITING

Clinical Research Site

Greenacres City, Florida 33647 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33606 - United States

Status: RECRUITING

Clinical Research Site

Winter Park, Florida 32789 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30318 - United States

Status: RECRUITING

And 210 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Primary Sjogrens Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships